Melatonin improves synapse development by PI3K/Akt signaling in a mouse model of autism spectrum disorder
摘要Autism spectrum disorders are a group of neurodevelopmental disorders involving more than 1100 genes,including Ctnmd2 as a candidate gene.Ctnnd2 knockout mice,serving as an animal model of autism,have been demonstrated to exhibit decreased density of dendritic spines.The role of melatonin,as a neurohormone capable of effectively alleviating social interaction deficits and regulating the development of dendritic spines,in Ctnnd2 deletion-induced nerve injury remains unclear.In the present study,we discovered that the deletion of exon 2 of the Ctnnd2 gene was linked to social interaction deficits,spine loss,impaired inhibitory neurons,and suppressed phosphatidylinositol-3-kinase(PI3K)/protein kinase B(Akt)signal pathway in the prefrontal cortex.Our findings demonstrated that the long-term oral administration of melatonin for 28 days effectively alleviated the aforementioned abnormalities in Ctnnd2 gene-knockout mice.Furthermore,the administration of melatonin in the prefrontal cortex was found to improve synaptic function and activate the PI3K/Akt signal pathway in this region.The pharmacological blockade of the PI3K/Akt signal pathway with a PI3K/Akt inhibitor,wortmannin,and melatonin receptor antagonists,luzindole and 4-phenyl-2-propionamidotetralin,prevented the melatonin-induced enhancement of GABAergic synaptic function.These findings suggest that melatonin treatment can ameliorate GABAergic synaptic function by activating the PI3K/Akt signal pathway,which may contribute to the improvement of dendritic spine abnormalities in autism spectrum disorders.
更多相关知识
- 浏览30
- 被引0
- 下载6

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



